Int J Pharm
May 2017
The focus was on the development of medicated foam for incorporation of two incompatible active agents for psoriasis treatment; i.e., lipophilic cholecalciferol, and hydrophilic salicylic acid.
© LitMetric 2024. All rights reserved.